.Attribute Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint asks for incorporation of clients along with MASLD and size of liver end results in cardio-- renal-- metabolic tests, when information suggest mechanistically plausible perks and also scientific security-- and summarizes points to consider for trial style and governing approval.